Objectives Mycobacterium abscessus is an opportunistic respiratory pathogen in patients
with underlying lung disease. It is infamously known for its low treatment success rates …

The basis of drug resistance in Mycobacterium abscessus is still poorly understood.
Nevertheless, as seen in other microorganisms, the efflux of antimicrobials may also play a …

Mycobacterium abscessus, a leading cause of severe lung infections in
immunocompromised individuals, poses significant challenges for current therapeutic …

Mycobacterium abscessus is a human pathogen responsible for severe respiratory
infections, particularly in patients with underlying lung disorders. Notorious for being highly …

Background: Mycobacterium abscessus is notorious for being intrinsically resistant to most
antibiotics. Antibiotic efflux is one of the mechanisms used by M. abscessus to pump out …

Purpose The emergence of clarithromycin resistance is a challenge in treating
Mycobacterium abscessus infections. Known mechanisms that contribute to intrinsic …

The incidence and prevalence of non-tuberculous mycobacterial (NTM) infections have
been increasing worldwide and lately led to an emerging public health problem. Among …

Mycobacterium abscessus (M. abscessus) inherently displays resistance to most antibiotics,
with the underlying drug resistance mechanisms remaining largely unexplored. Efflux pump …

Mycobacterium abscessus is an emerging human pathogen causing severe pulmonary
infections and is refractory to standard antibiotherapy, yet few drug resistance mechanisms …

Mycobacterium abscessus is an opportunistic pathogen notorious for its resistance to most
classes of antibiotics and low cure rates. M. abscessus carries an array of mostly unexplored …